Rare diseases
Investigational molecules
Locations
101 Rue De Tolbiac, 75654 Paris, France
Unicancer funds a broad programme in breast cancer, with strong activity in hormone receptor-positive, HER2-negative, and triple-negative breast cancer settings. Its trials address early breast cancer, metastatic breast cancer, brain metastases, leptomeningeal disease, and treatment adaptation based on ctDNA and molecular markers.
Research also includes endocrine therapy, CDK4/6 inhibition, antibody-drug conjugates, and risk-adapted strategies for patients with residual disease or low-risk recurrence profiles.
Unicancer runs clinical trials in conditions such as Hormone receptor positive HER2 negative breast cancer, Triple negative breast cancer, Breast cancer metastatic, Breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumFranceFranceFranceFranceFranceFranceFranceFranceBelgiumFranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
